European ScreeningPort GmbH

European ScreeningPort is a public private partnership which offers fee-for-service small molecule screening to academic institutions. Our goal is to provide the missing link in Europe between academic research and the Pharmaceutical industry and thereby to accelerate the translation of promising results generated in basic research into new therapeutics.

European ScreeningPort enables academic research institutes to access its state-of-the-art screening platform, its extensive collection of compounds as well as its sample and data processing capabilities. The inputs at European ScreeningPort are novel or under-exploited therapeutic targets with great potential, but which may lack either tractable lead series or supporting clinical Proof-of-Concept (PoC) data. Outputs range from tool compounds for mechanistic studies and PoC programs, through to high quality drug-like lead compounds suitable for progression to the pre-clinical candidates stage.